In summary, we have elucidated a new PRDX3-mediated mechanism of LNM in CCa, where PRDX3 could promote tumor cell invasion, lymphangiogenesis and LNM via NF-κB signaling pathway and scavenging ROS level to resist anoikis. This evidence concerns the gene NFKB1 and neoplasm.